Abstract
The October 1 start of the federal government’s 2018 fiscal year marked the beginning of the fifth renewal of the Prescription Drug User Fee Act (PDUFA) and the first-ever reauthorization of user fee acts for biosimilar products and generic drugs. The first version of PDUFA was enacted in 1992 to
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
Paper Title
Journal
Date
